Search Results 7561-7570 of 33695 for oral

  1. Publications - Zech G. Franks, M.D. - Mayo Clinic

    ACE2 and TAS2R38 receptor expression in pediatric and adult patients in the nasal and oral cavity. Laryngoscope Investig Otolaryngol. 2024 Feb; 9(1):e1207 ...

  2. Small bowel cancer - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer, Skin cancer, Squamous cell ...

  3. Myomectomy - Care at Mayo Clinic

    Oral gonadotropin-releasing hormone antagonists for the treatment of uterine leiomyomas. Obstetrics & Gynecology. 2023; doi:10.1097/AOG.0000000000005145 ...

  4. Slow Opioid Tapering Pilot Study - Clinical Trials

    tablet or capsule characteristics which allow encapsulation by the Research Pharmacy. Participants who have been prescribed the following oral opioids will be ...

  5. Study of AMG 650 in Adult Participants With Advanced Solid Tumors - Mayo Clinic

    Ability to take oral medications and willing to record daily adherence to Investigational product. Baseline QTc ≤ 470 msec for females and ≤ 450 msec for ...

  6. A Phase 1B/​2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies (ARTACUS) - Mayo Clinic

    Patients who require intermittent or chronic use of systemic (oral or intravenous) anti-virals with known anti-herpetic activity (e.g., acyclovir) unless for ...

  7. Study of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy in Subjects with Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    - Concomitant anticoagulation with oral anticoagulants (some specific exceptions apply) - Administration of a live, attenuated vaccine within 30 days prior ...

  8. Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome - Mayo Clinic

    treatment-naïve subjects. 2. Subjects currently treated with lanreotide, octreotide long acting release, or short acting octreotide (subcutaneous or oral) who ...

  9. myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home - Mayo Clinic

    - An approved hormonal contraceptive such as oral contraceptives, emergency contraception used as directed, patches, implants, injections, rings or ...

  10. Cancer - Mayo Clinic News Network

    New CT imaging oral contrast agent improves ...